The Eurasian Patent Office registered invention No. 42000, owned by the American company Regeneron Pharmaceuticals Inc. The patent discloses new antibody variants that can be used to treat a wide range of cancers: blood cancer, brain cancer, kidney cancer, etc.
Regeneron Pharmaceuticals Inc. - is an active user of the Eurasian patent system. The company holds 56 Eurasian patents for inventions, with a total of 222 patent applications filed on behalf of Regeneron Pharmaceuticals Inc.
Source - EAPO
More IP news – in our social networks (Facebook, Instagram, Telegram).